09:13 AM EST, 12/16/2024 (MT Newswires) -- Health care stocks were mixed premarket Monday as the Health Care Select Sector SPDR Fund ( XLV ) was up 0.1% and the iShares Biotechnology ETF (IBB) was down 0.4%.

Edgewise Therapeutics ( EWTX ) shares soared 14% after it said a phase 2 trial of sevasemten to treat patients with Becker muscular dystrophy met its primary endpoint of change from baseline in creatine kinase.

PureTech Health ( PRTC ) shares jumped 13% after it said that a phase 2 clinical trial of its drug deupirfenidone as a treatment of patients with idiopathic pulmonary fibrosis reached its primary endpoint.

Foghorn Therapeutics ( FHTX ) shares fell 17% after it said it has decided to discontinue the independent development of FHD-286 in combination with decitabine to treat patients with relapsed and/or refractory acute myeloid leukemia.